89BIO INC (ETNB) Stock Analyst Earnings Estimates
NASDAQ:ETNB - Nasdaq - US2825591033 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 1,284.05% | N/A 185.47% | N/A 115.84% | N/A 73.57% | N/A 1.61% | N/A 15.76% | |||||||
| EBITDA YoY % growth | -15.15M | -26.62M -75.71% | -49.3M -85.20% | -89.66M -81.87% | -102.18M -13.96% | -151.154M -47.93% | N/A -112.30% | N/A -0.53% | N/A -23.45% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.16M | -26.64M -75.73% | -49.36M -85.29% | -89.74M -81.81% | -102.25M -13.94% | -151.204M -47.88% | N/A -136.03% | N/A 11.04% | N/A -13.54% | N/A 27.21% | N/A 36.38% | N/A 210.91% | N/A 240.85% | N/A 34.98% | N/A 24.34% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -3.10 78.22% | -4.48 -44.52% | -3.54 20.98% | -2.01 43.22% | N/A -62.39% | N/A 18.98% | N/A -6.27% | N/A 35.48% | N/A 18.05% | N/A 101.15% | N/A 6,516.77% | N/A 182.35% | N/A 55.77% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.79 -57.37% | -0.67 -23.91% | -0.67 -39.83% | -0.68 50.83% | -0.73 7.53% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -72.287M -75.64% | -79.473M -38.77% | -81.661M -52.88% | -83.961M 44.73% | -70.462M 2.53% |
| EBIT Q2Q % growth | -87.905M -113.33% | -79.203M -38.28% | -79.165M -48.15% | -82.687M 45.58% | -86.602M 1.48% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.39 -208.89% | -0.65 | -0.74 | -112.45% |
| Q2 2024 Q2Q % growth | -0.48 7.69% | -0.58 | 0.10 | 17.40% |
| Q1 2024 Q2Q % growth | -0.54 | -0.47 | -0.07 | -14.78% |
| Q4 2023 Q2Q % growth | -0.50 -4.17% | -0.50 | 0.00 | 0.97% |
| Q3 2023 Q2Q % growth | -0.45 21.05% | -0.54 | 0.09 | 16.76% |
| Q2 2023 Q2Q % growth | -0.52 57.72% | -0.42 | -0.10 | -23.91% |
| Q1 2023 Q2Q % growth | -0.54 57.14% | -0.53 | -0.01 | -1.48% |
| Q4 2022 Q2Q % growth | -0.48 63.08% | -0.70 | 0.22 | 31.43% |
| Q3 2022 Q2Q % growth | -0.57 59.57% | -0.81 | 0.24 | 29.93% |
| Q2 2022 Q2Q % growth | -1.23 -19.42% | -1.07 | -0.16 | -14.52% |
| Q1 2022 Q2Q % growth | -1.26 -70.27% | -1.32 | 0.06 | 4.45% |
| Q4 2021 Q2Q % growth | -1.30 -106.35% | -1.33 | 0.03 | 2.58% |
| Q3 2021 Q2Q % growth | -1.41 -63.95% | -1.08 | -0.33 | -30.92% |
| Q2 2021 Q2Q % growth | -1.03 -21.18% | -0.86 | -0.17 | -20.42% |
| Q1 2021 Q2Q % growth | -0.74 2.63% | -0.71 | -0.03 | -4.69% |
| Q4 2020 Q2Q % growth | -0.63 75.58% | -0.89 | 0.26 | 29.01% |
| Q3 2020 Q2Q % growth | -0.86 97.19% | -0.86 | 0.00 | -0.39% |
| Q2 2020 Q2Q % growth | -0.85 | -0.85 | 0.00 | 0.20% |
| Q1 2020 Q2Q % growth | -0.76 | -0.88 | 0.12 | 13.69% |
| Q4 2019 Q2Q % growth | -2.58 | -0.96 | -1.62 | -168.37% |
| Q3 2019 Q2Q % growth | -30.63 | -1.23 | -29.40 | -2,395.53% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 546.424K | -546.424K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2% | 2% | 0.97% | -32.62% |
| Revenue | N/A | N/A | N/A | -100% |